{
  "trial_id": "NCT01775501",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Histologically confirmed advanced HCC",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Barcelona Clinic Liver Cancer stage C or stage B if you cannot tolerate or failed TACE",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "No cirrhosis or Child-Pugh A cirrhosis",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Measurable lesions",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "All acute toxic effects of any prior treatment have resolved to NCI-CTCAE v4.0 grade 1 or less",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Able to swallow and retain oral medication",
      "label": "unknown",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Prior systemic regimens for HCC",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Uncontrolled hypertension",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "CLIP score > 3",
      "label": "triggers",
      "evidence": "unknown"
    },
    {
      "criterion": "ECOG PS > 1",
      "label": "triggers",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has a history of CLL and large cell transformation, with bulky lymphadenopathy. He has had multiple treatments, including FCR, PCR, R-CVP, and Campath, but has not responded well to therapy.",
  "_meta": {
    "topic_id": "8",
    "trial_id": "NCT01775501",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}